Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jufeng Wan
Observed names:
J. Wan,
JUEFENG WAN,
Juefeng WAN,
Juefeng Wan,
Wan, Juefeng
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
Observed institutions:
Shanghai Medical College of Fudan University,
Harbin Medical University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
ORCID:
0009-0009-5096-9622
Observed ORCID:
0009-0009-5096-9622
OpenAlex ID:
A5075868853
SHP2 potentiates anti-PD-1 effectiveness through intervening cell pyroptosis resistance in triple-negative breast cancer
2023
·
Chao Chen
, Yuanyuan Cheng
, et al.
·
Biomedicine & Pharmacotherapy
·
12
Unveiling radiobiological traits and therapeutic responses of BRAFV600E-mutant colorectal cancer via patient-derived organoids
2025
·
Peiyuan Mu
, Shaobo Mo
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
11
Obesity-driven oleoylcarnitine accumulation in tumor microenvironment promotes breast cancer metastasis-like phenotype
2025
·
Chao Chen
, Hongxia Zhang
, et al.
·
Acta Pharmaceutica Sinica B
·
8
Short-Course Radiotherapy Based Total Neoadjuvant Therapy Combined with Toripalimab for Locally Advanced Rectal Cancer: Preliminary Findings from a Randomized, Prospective, Multicenter, Double-Arm, Phase II Trial (TORCH)
2022
·
Y. Wang
, F. Xia
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
6
Inhibition of hERG by ESEE suppresses the progression of colorectal cancer
2024
·
Jufeng Wan
, Haiying Xu
, et al.
·
Translational Oncology
·
5
Fecal microbiome and metabolome dynamics during immunotherapy-based total neoadjuvant therapy in rectal cancer: associations with treatment response and toxicity
2026
·
Weiqing Lu
, Yaqi Wang
, et al.
·
Frontiers in Immunology
·
3
PDF
Short-Course Radiotherapy Combined With CapeOx and PD-1 Inhibitor Following Local Excision in High-Risk Early Rectal Cancer: Study Protocol for a Prospective Phase II Trial (TORCH-LE)
2026
·
Jingwen Wang
, Yan Wang
, et al.
·
Clinical Medicine Insights Oncology
·
1
Pathological lymph node response after immunotherapy-based total neoadjuvant therapy supports local excision for organ preservation in locally advanced rectal cancer: a propensity-score weighted analysis
2026
·
Shujuan Zhou
, Maoguang Ma
, et al.
·
Clinical and Translational Radiation Oncology
·
1
PDF
Neoadjuvant immunotherapy combined with radiochemotherapy vs chemotherapy alone in pMMR colon cancers: The TORCH-C randomized phase 2 clinical trial.
2026
·
Hui Zhang
, Yaqi Li
, et al.
·
Journal of Clinical Oncology
·
1
Application of genetic features and serial ctDNA in estimating response and prognosis of immunotherapy-based total neoadjuvant therapy (iTNT) for microsatellite stable locally advanced rectal cancer: data from TORCH trial
2026
·
Yaqi Wang
, Yang Xu
, et al.
·
Genome Medicine
Quality of life and anorectal function in rectal cancer patients undergoing immunotherapy-based total neoadjuvant therapy: a comparison of organ preservation and radical surgery
2026
·
Luoxi He
, Zonglin Lv
, et al.
·
Clinical and Translational Radiation Oncology
PDF
Analysis code accompanying the TORCH biomarker study
2026
·
Wang, Yaqi
, Xu, Yang
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Comparison of Thrombocytopenia and Splenomegaly in Locally Advanced Rectal Cancer Patients Receiving Total Neoadjuvant Therapy With and Without Immunotherapy
2026
·
Shuwen Li
, Mingxu Yan
, et al.
·
Cancer Medicine
Integrating clinical and genomic features to predict response to neoadjuvant therapy in microsatellite-stable rectal cancer
2026
·
Lijie Zhang
, Jingwen Wang
, et al.
·
Therapeutic Advances in Medical Oncology
Radiotherapy followed by CAPOX plus tislelizumab in microsatellite-stable rectal cancer with synchronous resectable metastases: Updated results of the MIRACLE-1 study.
2026
·
Menglong Zhou
, Zezhi Shan
, et al.
·
Journal of Clinical Oncology
Radiotherapy followed by systemic therapy and tislelizumab in microsatellite-stable rectal cancer with synchronous unresectable metastases: Updated results of the MIRACLE-2 study.
2026
·
Menglong Zhou
, Lijun Shen
, et al.
·
Journal of Clinical Oncology
A prospective randomized controlled trial of FAPI PET/CT-guided radiotherapy combined with second-line standard systemic treatment and cadonilimab versus second-line standard systemic treatment alone in patients with peritoneal metastasis from colorectal cancer (TORCH-PM01).
2026
·
Juefeng Wan
, Weixing Dai
, et al.
·
Journal of Clinical Oncology
Immunotherapy-based total neoadjuvant therapy with or without short-course radiotherapy for locally advanced rectal cancer: Preliminary results of TORCH-iTNT.
2026
·
Yaqi Wang
, Lijun Shen
, et al.
·
Journal of Clinical Oncology
3063 Neoadjuvant radiotherapy combined with CAPOX and PD-1 inhibitor for MSS/pMMR high-risk locally advanced colon cancer: a randomized phase II Trial
2026
·
Hui Zhang
, Fan Xia
, et al.
·
Radiotherapy and Oncology
789 Radiotherapy combined with chemoimmunotherapy in gastric cancer with limited lymph node metastases: Preliminary results of the MIRACLE-G study
2026
·
Menglong Zhou
, Jing Guo
, et al.
·
Radiotherapy and Oncology
2846 Immunotherapy based total neoadjuvant therapy with or without short-course radiotherapy for locally advanced rectal cancer (TORCH-iTNT NCT06281405)
2026
·
Yaqi Wang
, Lijun Shen
, et al.
·
Radiotherapy and Oncology
1821 Comparison of Total Neoadjuvant Therapy with or without PD-1 blockade (iTNT vs TNT) for Locally Advanced Rectal Cancer
2026
·
Qianyu Zhou
, Yaqi Wang
, et al.
·
Radiotherapy and Oncology
1480 dynamic interplay between gut microbiota and metabolism during immunotherapy-based total neoadjuvant therapy in early low rectal cancer
2026
·
Mingxu Yan
, Yajie Chen
, et al.
·
Radiotherapy and Oncology
90 A Phase Ib/II Trial of Radiotherapy Combined with Doxorubicin and Sintilimab for Localized High-Risk Limbs and Trunk Soft Tissue Sarcomas
2026
·
Yan WANG
, Shujuan ZHOU
, et al.
·
Radiotherapy and Oncology
880 Hypofractionated radiotherapy combined with immunotherapy and chemotherapy for locally recurrent rectal cancer: a prospective, phase II trial
2026
·
JUEFENG WAN
, Ruiyan Wu
, et al.
·
Radiotherapy and Oncology
Show more works
View as search
Works count:
42
Citation count:
48
H-index:
5
I10-index:
2
Year
Topic
Type